These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

669 related items for PubMed ID: 23704278

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer.
    Yau TO, Wu CW, Tang CM, Chen Y, Fang J, Dong Y, Liang Q, Ng SS, Chan FK, Sung JJ, Yu J.
    Oncotarget; 2016 Jan 12; 7(2):1559-68. PubMed ID: 26621842
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum miR-199a as a potential diagnostic biomarker for detection of colorectal cancer.
    Tan HY, Zheng YB, Liu J.
    Eur Rev Med Pharmacol Sci; 2018 Dec 12; 22(24):8657-8663. PubMed ID: 30575906
    [Abstract] [Full Text] [Related]

  • 11. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Lv ZC, Fan YS, Chen HB, Zhao DW.
    Tumour Biol; 2015 Mar 12; 36(3):1619-25. PubMed ID: 25528214
    [Abstract] [Full Text] [Related]

  • 12. The ratio of miR-21/miR-24 as a promising diagnostic and poor prognosis biomarker in colorectal cancer.
    Hao JP, Ma A.
    Eur Rev Med Pharmacol Sci; 2018 Dec 12; 22(24):8649-8656. PubMed ID: 30575905
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer.
    Yuan Z, Baker K, Redman MW, Wang L, Adams SV, Yu M, Dickinson B, Makar K, Ulrich N, Böhm J, Wurscher M, Westerhoff M, Medwell S, Moonka R, Sinanan M, Fichera A, Vickers K, Grady WM.
    Br J Cancer; 2017 Oct 10; 117(8):1202-1210. PubMed ID: 28809863
    [Abstract] [Full Text] [Related]

  • 17. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
    Wang LL, Du LT, Li J, Liu YM, Qu AL, Yang YM, Zhang X, Zheng GX, Wang CX.
    World J Gastroenterol; 2014 Aug 28; 20(32):11340-6. PubMed ID: 25170220
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of microRNA-16 expression in human colorectal cancer.
    Qian J, Jiang B, Li M, Chen J, Fang M.
    World J Surg; 2013 Dec 28; 37(12):2944-9. PubMed ID: 24045965
    [Abstract] [Full Text] [Related]

  • 19. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P, Padilla D, Villarejo P, Palomino T, Nieto P, Menéndez JM, Rodríguez-Montes JA.
    J Surg Oncol; 2013 Nov 28; 108(6):369-73. PubMed ID: 23970420
    [Abstract] [Full Text] [Related]

  • 20. Reduced serum exosomal miR-874 expression predicts poor prognosis in colorectal cancer.
    Zhang N, Zhang PP, Huang JJ, Wang ZY, Zhang ZH, Yuan JZ, Ma EM, Liu X, Bai J.
    Eur Rev Med Pharmacol Sci; 2020 Jan 28; 24(2):664-672. PubMed ID: 32016967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.